Gluskin Sheff & Assoc Inc Novartis Ag Transaction History

Gluskin Sheff & Assoc Inc

$814 Million
Q3 2024

A detailed history of Gluskin Sheff & Assoc Inc transactions in Novartis Ag stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 37,733 shares of NVS stock, worth $3.71 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

37,733

Previous 35,733 5.6%

Holding current value

$3.71 Million

Previous $3.8 Million 14.09%

% of portfolio

0.53%

Previous 0.46%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$106.13 - $120.89 $212,260 - $241,780	2,000 Added 5.6%	37,733 $4.34 Million
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $740,560 - $858,960	-8,000 Reduced 18.29%	35,733 $3.8 Million
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $1.14 Million - $1.3 Million	-12,000 Reduced 21.53%	43,733 $4.23 Million
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $2.25 Million - $2.48 Million	-24,415 Reduced 30.46%	55,733 $5.63 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $47,365 - $52,565	-500 Reduced 0.62%	80,148 $8.16 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $1.76 Million - $2 Million	19,020 Added 30.86%	80,648 $8.14 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $1.64 Million - $1.9 Million	20,500 Added 49.84%	61,628 $5.67 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $5,590 - $6,846	74 Added 0.18%	41,128 $3.73 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $2.32 Million - $2.71 Million	-31,096 Reduced 43.1%	41,054 $3.12 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $656,962 - $764,906	-8,159 Reduced 10.16%	72,150 $6.1 Million
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $139,231 - $157,497	-1,738 Reduced 2.12%	80,309 $7.05 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $7.97 Million - $8.81 Million	-100,000 Reduced 54.93%	82,047 $7.18 Million
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $3.27 Million - $3.81 Million	40,000 Added 28.16%	182,047 $14.9 Million
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $1.26 Million - $1.39 Million	14,796 Added 11.63%	142,047 $13 Million
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $3.25 Million - $3.83 Million	38,928 Added 44.07%	127,251 $10.9 Million
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $780,699 - $944,300	10,000 Added 12.77%	88,323 $8.34 Million
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $13,963 - $15,470	170 Added 0.22%	78,323 $6.81 Million
Q2 2020 Aug 11, 2020	SELL	$80.93 - $91.1 $4.03 Million - $4.54 Million	-49,800 Reduced 38.92%	78,153 $6.83 Million
Q1 2020 May 13, 2020	SELL	$70.67 - $99.01 $76,040 - $106,534	-1,076 Reduced 0.83%	127,953 $10.5 Million
Q4 2019 Feb 12, 2020	BUY	$84.35 - $95.37 $1.27 Million - $1.43 Million	15,030 Added 13.18%	129,029 $12 Million
Q3 2019 Nov 08, 2019	SELL	$85.54 - $94.26 $2.64 Million - $2.91 Million	-30,820 Reduced 21.28%	113,999 $9.91 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $3.64 Million - $4.48 Million	-48,235 Reduced 24.99%	144,819 $13.2 Million
Q1 2019 May 10, 2019	SELL	$75.32 - $86.15 $1.85 Million - $2.12 Million	-24,601 Reduced 11.3%	193,054 $18.6 Million
Q4 2018 Feb 12, 2019	SELL	$73.66 - $82.02 $2.9 Million - $3.23 Million	-39,320 Reduced 15.3%	217,655 $18.7 Million
Q3 2018 Nov 09, 2018	SELL	$66.94 - $77.43 $45,519 - $52,652	-680 Reduced 0.26%	256,975 $22.1 Million
Q2 2018 Aug 13, 2018	SELL	$64.91 - $73.36 $46,735 - $52,819	-720 Reduced 0.28%	257,655 $19.5 Million
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $1.35 Million - $1.61 Million	-19,110 Reduced 6.89%	258,375 $20.9 Million
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $1.52 Million - $1.63 Million	20,970 Added 8.17%	277,485 $23.3 Million
Q3 2017 Nov 01, 2017	BUY	$74.14 - $77.27 $19 Million - $19.8 Million	256,515	256,515 $22 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.

Account

Gluskin Sheff & Assoc Inc Novartis Ag Transaction History